A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy
Public ClinicalTrials.gov record NCT04498169. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-Label, Parallel-Group Study to Evaluate the Safety and Efficacy of Two Dosing Regimens of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Two different dosing regimens (QD and BID) of netarsudil will be studied to evaluate their efficacy in reducing or resolving corneal edema in subjects with FCD.
Study identification
- NCT ID
- NCT04498169
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 17, 2020 (Actual)
- Primary completion
- Aug 11, 2021 (Actual)
- Completion
- Aug 11, 2021 (Actual)
- Last update posted
- Sep 15, 2022
2020 – 2021
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Orange County Ophthalmology | Garden Grove | California | 92843 | — |
| Harvard Eye Associates | Laguna Hills | California | 92653 | — |
| Cincinnati Eye Institute | Edgewood | Kentucky | 41017 | — |
| Advance Eye Associates | South Dartmouth | Massachusetts | 02748 | — |
| Chu Vision Institute | Bloomington | Minnesota | 55420 | — |
| Minnesota Eye Care | Minnetonka | Minnesota | 55305 | — |
| Ophthalmology Associates | St Louis | Missouri | 63131 | — |
| Vance Thompson Vision | West Fargo | North Dakota | 58078 | — |
| Comprehensive Eye Care | Westerville | Ohio | 43082 | — |
| Vance Thompson Vision | Sioux Falls | South Dakota | 57108 | — |
| Houston Eye Associates | Houston | Texas | 77025 | — |
| Virginia Eye Consultants | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04498169, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 15, 2022 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04498169 live on ClinicalTrials.gov.